Evidence map›Paper›PMID 22723832›Full record

ArticlePloS one2012

Estrogen modulates NFκB signaling by enhancing IκBα levels and blocking p65 binding at the promoters of inflammatory genes via estrogen receptor-β.

Dongqi Xing, Suzanne Oparil, Hao Yu, Kaizheng Gong, Wenguang Feng, Jonathan Black, Yiu-Fai Chen, Susan Nozell

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 1 synthesis or guideline pooled it, 137 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Estrogen-mediated NF-κB blockade enables breast cancer sensitivity to oncolytic VSV virotherapy.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Exploratory analysis of the impact of sex on sputum proteomic response to inhaled wood smoke in humans.Toxicological sciences : an official journal of the Society of Toxicology · 2026
    Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Effect of Estrogen on Sirt1 Signaling in Human Macrophages.International journal of molecular sciences · 2025
    Article
  18. Article
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Dongqi XingVascular Biology and Hypertension Program, Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. dqxing@uab.edu
Suzanne Oparil
Hao Yu
Kaizheng Gong
Wenguang Feng
Jonathan Black
Yiu-Fai Chen
Susan Nozell
University of Alabama at Birmingham · US

Funding

MECHANISMS OF HYPERTENSION AND CARDIOVASCULAR DISEASEST32HL007457 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Martin E Young · 1985 to 2026
$8.6M
UAB Diabetes Research and Training CenterP60DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GARVEY, W TIMOTHY · 2008 to 2012
$8.4M
UAB Short-Term Research Training in Health Professional Schools (SHRT)T35HL007473 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WILLIAM M GEISLER · 1985 to 2026
$4.0M
ATRIAL NATRIURETIC PEPTIDE IN PULMONARY HYPERTENSIONR01HL044195 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CHEN, YIU-FAI · 1990 to 2010
$2.6M
O-GlyNAcylation: Novel Mechanism of Estrogen-Induced VasoprotectionR01HL087980 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OPARIL, SUZANNE · 2009 to 2012
$1.4M
ANP Modulates Cardiac Remodeling via Cardiac FibroblastsR01HL080017 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CHEN, YIU-FAI · 2006 to 2009
$1.4M
Estrogen Modulates Injury-Induced InflammationR01HL075211 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OPARIL, SUZANNE · 2004 to 2007
$1.4M
NHLBI NIH HHS HL044195NHLBI NIH HHS HL07457NHLBI NIH HHS HL080017NHLBI NIH HHS HL087980NHLBI NIH HHS HL75211NHLBI NIH HHS R01 HL044195NHLBI NIH HHS R01 HL075211NHLBI NIH HHS R01 HL080017NHLBI NIH HHS R01 HL087980NHLBI NIH HHS T32 HL007457NHLBI NIH HHS T35 HL007473NIDDK NIH HHS P60 DK-079626NIDDK NIH HHS P60 DK079626
6 · The paper itself

Abstract

backgroundNFκB signaling is critical for expression of genes involved in the vascular injury response. We have shown that estrogen (17β-estradiol, E2) inhibits expression of these genes in an estrogen receptor (ER)-dependent manner in injured rat carotid arteries and in tumor necrosis factor (TNF)-α treated rat aortic smooth muscle cells (RASMCs). This study tested whether E2 inhibits NFκB signaling in RASMCs and defined the mechanisms. METHODOLOGY/PRINCIPAL

findingsTNF-α treated RASMCs demonstrated rapid degradation of IκBα (10-30 min), followed by dramatic increases in IκBα mRNA and protein synthesis (40-60 min). E2 enhanced TNF-α induced IκBα synthesis without affecting IκBα degradation. Chromatin immunoprecipitation (ChIP) assays revealed that E2 pretreatment both enhanced TNF-α induced binding of NFκB p65 to the IκBα promoter and suppressed TNF-α induced binding of NFκB p65 to and reduced the levels of acetylated histone 3 at promoters of monocyte chemotactic protein (MCP)-1 and cytokine-induced neutrophil chemoattractant (CINC)-2β genes. ChIP analyses also demonstrated that ERβ can be recruited to the promoters of MCP-1 and CINC-2β during co-treatment with TNF-α and E2.

conclusionsThese data demonstrate that E2 inhibits inflammation in RASMCs by two distinct mechanisms: promoting new synthesis of IκBα, thus accelerating a negative feedback loop in NFκB signaling, and directly inhibiting binding of NFκB to the promoters of inflammatory genes. This first demonstration of multifaceted modulation of NFκB signaling by E2 may represent a novel mechanism by which E2 protects the vasculature against inflammatory injury.

Indexed as

Promoter Regions, GeneticAnimalsCells, CulturedChemokine CCL2Chemokines, CXCEstrogen Receptor betaEstrogensFemaleGene Expression RegulationI-kappa B ProteinsMyocytes, Smooth MuscleNF-kappa BPhosphorylationProteolysisRatsRats, Sprague-DawleyChemokine CCL2Chemokines, CXCCxcl3 protein, ratEstrogen Receptor betaEstrogensI-kappa B ProteinsNF-kappa BTranscription Factor RelATumor Necrosis Factor-alpha

Identifiers

PMID22723832
PMCPMC3378567
OpenAlexW1996316514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.